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Abstract : Critically ill patients exhibit prominent muscle atrophy, which occurs rapidly after ICU admission and 
leads to poor clinical outcomes. The extent of atrophy differs among muscles as follows: upper limb: 0.7%–2.4% 
per day, lower limb: 1.2%–3.0% per day, and diaphragm 1.1%–10.9% per day. This atrophy is caused by numer-
ous risk factors such as inflammation, immobilization, nutrition, hyperglycemia, medication, and mechanical 
ventilation. Muscle atrophy should be monitored noninvasively by ultrasound at the bedside. Ultrasound can 
assess muscle mass in most patients, although physical assessment is limited to almost half of all critically ill pa-
tients due to impaired consciousness. Important strategies to prevent muscle atrophy are physical therapy and 
electrical muscular stimulation. Electrical muscular stimulation is especially effective for patients with limited 
physical therapy. Regarding diaphragm atrophy, mechanical ventilation should be adjusted to maintain spon-
taneous breathing and titrate inspiratory pressure. However, the sufficient timing and amount of nutritional in-
tervention remain unclear. Further investigation is necessary to prevent muscle atrophy and improve long-term 
outcomes. J. Med. Invest. 67 : 1-10, February, 2020
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INTRODUCTION
 
Mortality from critical illness has declined by 35% in the 
past few decades, accompanied by increased attention to func-
tional impairments in survivors (1). One-third of patients have 
functional impairments following ICU discharge, which is now 
recognized as post-intensive care syndrome (PICS) (2). PICS 
encompasses impaired physical, mental, and cognitive functions 
(3). Even 5 years after intensive care, the patients’ physical 
function does not return to the standard level (4), and one-third 
of survivors never return to work (5). Muscle weakness and 
atrophy acquired in the ICU are major contributors to PICS (6). 
Muscle weakness in the ICU has gained increased attention 
as ICU-acquired weakness (ICU-AW) (7). ICU-AW is bilateral 
muscle weakness newly acquired in the ICU and is observed in 
40-50% of critically ill patients (8, 9). In the ICU, prolonged bed 
rest and inflammation increase catabolism and microcirculato-
ry disturbances, which cause axonal degeneration and muscle 
protein breakdown (9). Therefore, ICU-AW is considered to be 
neuropathy (critical illness polyneuropathy) or myopathy (critical 
illness myopathy), as well as the overlap of these two conditions 
(10). ICU-AW is associated with a prolonged ICU stay and high 
mortality (6).   
Recently, many studies have investigated muscle atrophy be-
cause the diagnosis of ICU-AW is challenging (11, 12). Although 
the diagnosis of ICU-AW requires assessment of limb muscle 
strength, more than half of all critically ill patients cannot com-
ply with the evaluation (13). In contrast, muscle atrophy can be 
evaluated for all critically ill patients. This muscle atrophy is as-
sociated with ICU-AW and encompasses the concept of ICU-AW 
(14). In addition to limbs, respiratory muscle can atrophy and 
impede weaning from mechanical ventilation (15). Recent stud-
ies found that early mobilization and neuromuscular electrical 
stimulation can prevent and treat muscle atrophy in critically ill 
patients (16). This review focuses on the causes, evaluation, and 
prevention of muscle atrophy in critically ill patients.
1. MUSCLE ATROPHY
Noticeable reduction of muscle mass starts within 3 days of 
ICU stay, and progressively worsens thereafter (17). Patients 
with acute respiratory distress syndrome (ARDS) had a weight 
loss of 18% at hospital discharge, mostly due to muscle atrophy 
(18). Even 6 to 12 months after ICU discharge, survivors of 
ARDS did not regain their original muscle mass proportion, 
and the decreased muscle mass was associated with impaired 
gait speed (r = 0.27–0.41, p < 0.05) and 6-minute walk distance 
(r = 0.36–0.42, p < 0.001) (19). The extent of muscle atrophy 
acquired in the ICU is different among skeletal muscles (20). 
Therefore, each muscle is explained separately.
1-1. Lower limbs
In our previous study, we found that the rectus femoris thick-
ness and cross-sectional area decreased by 18.8% and 20.7%, 
respectively, during the first 7 days (17). In other studies, the 
muscle mass of the rectus femoris decreased by 10.6% or 17.7–
29.9% over 7 or 10 days (14, 21, 22). The muscle mass decreased 
by 29.7% in the vastus intermedius, by 14.1%–22.9% in the 
vastus lateralis, and by 11.6% in the gastrocnemius (22, 23) over 
10 days. The mass of the tibialis anterior muscle decreased by 
21% over 9 days (24). Thus, the atrophy rate in lower limbs is 
1.2%–3.0% per day (17, 21-23). Similarly, in pediatric patients, 
the thickness of the quadriceps femoris muscle decreased by 
1.5% per day (25). The decreased quadriceps cross-sectional area 
during the ICU stay further decreased 7 days after ICU dis-
charge, and the muscle atrophy remained in 73% of patients with 
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impaired physical function 6 months after ICU discharge (26). 
1-2. Upper limbs
Muscle atrophy in upper limbs is controversial. In our previous 
study, the thickness and cross-sectional area of the biceps brachii 
muscle decreased by 13.2% and 16.9%, respectively, over the 
7 days of ICU admission (17). Similarly, in septic patients, the 
muscle thickness decreased by 7.6% over the 7 days (14). On the 
other hand, Turton et al. found that the muscle thickness of the 
upper limbs in ICU patients did not decrease significantly from 
ICU admission to the 10th day (3.20 ± 0.58 cm to 2.98 ± 0.83 cm, 
p = 0.62), although the lower limb muscle mass significantly de-
creased (23). In another study, the muscle thickness of the upper 
limbs did not change in bed-ridden healthy volunteers (27). The 
differences may be explained by the severity of illness or patient’s 
consciousness because less critical patients can use their arms 
during bed rest, and such activation of biceps brachii muscles 
may have counteracted the atrophy. Similarly, in critically ill 
pediatric patients, biceps muscle atrophy did not significantly 
change (-1.71% ; 95% CI, -8.15% to 4.73% ; p = 0.59) over the 6 
days (25). In conclusion, the atrophy rate of the upper limbs is 
lower than that of the lower limbs, at 0.7%–2.4% per day in crit-
ically ill patients (14, 17, 23).
1-3. Pectoralis major muscle
The pectoralis major muscle is important in critically ill pa-
tients because a larger pectoralis major muscle was related to 
a higher 6-month survival rate (odds ratio [OR], 1.03 ; 95% CI, 
1.01-1.04 ; P < .001) (28). Over the 5 days of ICU admission, the 
atrophy of the pectoralis major muscle was limited to only 29% 
of patients, and the change in thickness was not significant (5.6 
mm [4.8–6.9] to 5.9 mm [4.9–7.0], p = 0.308) (29). Similarly, 
Levine et al. found that the muscle fibers of the pectoralis major 
muscle did not differ between mechanically ventilated patients 
and control subjects, although the study only compared 22 pa-
tients with different pathologies (30). Further investigation is 
needed to conclude the rate of atrophy of the pectoralis major 
muscle.
1-4. Diaphragm
Patients undergoing prolonged mechanical ventilation have 
sustained diaphragm muscle loss, which leads to poorer clinical 
outcomes (15). Diaphragm muscle atrophy occurs in 41–44% 
of patients according to previous studies (15, 31). Diaphragm 
muscle atrophy is separated from limb muscle atrophy because 
it is constantly activated by mechanical ventilation, whereas the 
limb muscles are not constantly active. Thus, in a previous study, 
the correlation between diaphragm dysfunction and limb muscle 
weakness was weak (r = 0.26–0.28, p ≤ 0.03), and only 21% of 
patients had both diaphragm and limb muscle weakness (20). 
In another study, diaphragm atrophy was more prominent than 
psoas muscle atrophy at 25 days after the first measurement 
(diaphragm vs. psoas : -27% ± 12% vs. -19% ± 13%) (32). The 
atrophy rate of the diaphragm is 2.4%–10.9% per day during me-
chanical ventilation (31, 33, 34) and 1.1%–2.4% per day during 
ICU stay (29, 32). In pediatric patients, the diaphragm atrophy 
rate was 3.4% per day during mechanical ventilation (35). 
Of note, the diaphragm exhibits not only atrophy, but also hy-
pertrophy (36). Hypertrophy occurs in 12%–24% of mechanically 
ventilated patients (15, 31). In patients with diaphragm hyper-
trophy, the diaphragm thickness increased by approximately 
17% over the 8 days of mechanical ventilation. The diaphragm 
muscle can be thickened by insufficient ventilatory support and 
excessive inspiratory load because this condition functions as 
resistance training of the diaphragm muscle (34). As such, di-
aphragm hypertrophy is associated with prolonged mechanical 
ventilation (OR, 1.38 ; 95% CI, 1.00–1.90) (15). However, the 
clinical implications of diaphragm hypertrophy require further 
investigation because few studies have been reported (15, 34).
1-5 Other respiratory muscles
In addition to the diaphragm, other respiratory muscles play 
an important role in moving the rib cage in patients with acute 
respiratory failure who have difficulty breathing (37). Among 
other respiratory muscles, the intercostal muscles exhibited 
atrophy in rabbits (38). In the study, the intercostal muscle mass 
decreased by 29% over the 48 hours of mechanical ventilation. In 
chronic obstructive pulmonary disease (COPD), the intercostal 
muscle can atrophy due to progression of the disease (39). How-
ever, the atrophy of intercostal muscles and other accessary re-
spiratory muscles, including the sternocleidomastoid and rectus 
abdominis muscles, is unclear in critically ill patients.
2. RISK FACTORS
2-1. Inflammation
Inflammation is the main cause of muscle atrophy in the early 
course of critical illness (Fig. 1) (40). In patients who develop 
ICU-AW, the level of inflammatory cytokines, including inter-
leukin 6, 8, and 10, was significantly higher (OR, 1.35 ; 95% CI, 
1.18–1.55) in the first 4 days after ICU admission (41). Intra-
muscular inflammation causes catabolism and impairs anabolic 
signaling with consequent muscle mass reduction (42, 43). Sep-
sis accompanies systemic inflammation, and leads to upper and 
lower limb muscle atrophy (14). Moreover, multiple organ failure, 
which is often the consequence of inflammation, leads to promi-
nent muscle atrophy (21).
2-2. Immobilization
Critically ill patients are often immobilized due to the se-
verity of illness and equipment such as mechanical ventilation 
(44). This immobilization leads to muscle atrophy (45). Even in 
healthy volunteers, the bed-ridden state causes the lower limb 
muscles to atrophy by 0.2%–0.6% per day (27, 46). However, 
patients in the ICU exhibit more prominent muscle atrophy at 
1.2%–3.0% per day due to multiple causes (45). 
2-3. Nutrition
Although catabolism plays a greater role in muscle atrophy 
than impaired synthesis (47), malnutrition is also an important 
cause of muscle atrophy (45). The nutrition of critically ill pa-
tients is often delayed or interrupted (48). Moreover, patients in 
the ICU frequently have problems absorbing the nutrition due to 
the enteral intolerance (49).
2-4. Hyperglycemia
Hyperglycemia is often a consequence of inflammation, but 
it is identified as an independent risk factor for muscle atrophy 
because it impairs mitochondrial function (50) and promotes the 
muscle atrophy pathway (51). Moreover, hyperglycemia second-
arily causes ischemia of muscles and nerves (10), and is associat-
ed with ICU-AW (OR, 2.86 ; 95% CI, 1.30–6.30 ; p = 0.009) (52). 
2-5. Medication
Neuromuscular-blocking agents are often used for ARDS as 
a lung-protective strategy. However, their effects on muscle and 
physical function are unclear. In a recent study of ARDS, neuro-
muscular-blocking agents lead to a higher incidence of ICU-AW, 
although not significantly (47.3% in intervention vs. 39.0% in 
the control) (13). In a meta-analysis of a general ICU population, 
neuromuscular-blocking agent usage was associated with the 
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risk of ICU-AW (OR, 2.03 ; 95% CI, 1.22–3.40) (53). For the 
diaphragm, neuromuscular-blocking agents caused significant 
muscle atrophy (-16.4% [IQR, -28.4% to -7.0%] for neuromus-
cular-blocking agents vs. -7.3% [IQR, -10.9% to 0%] for control, 
p = 0.036) (35)
Steroids are frequently used in the ICU, but they should be 
used carefully because they inhibit protein synthesis and acti-
vate protein degradation (54). Indeed, steroid use is associated 
with pectoral muscle atrophy (Atrophy ratio : 58% in patients 
treated by steroids vs. 14% in the control, p = 0.006)  (28) and 
ICU-AW (OR, 1.84 ; 95% CI, 1.26–2.67) (55). The combined use 
of steroids and neuromuscular-blocking agents is more deleteri-
ous to muscle than steroids alone (56). 
Catecholamines can maintain organ perfusion in shock. Al-
though arrhythmias and ischemia are well-known side effects, a 
recent study found that catecholamines are associated with ICU-
AW (OR, 3.20 ; 95% CI, 1.29–7.95) (55). During the use of cate-
cholamines, the stimulation of β-adrenergic receptors has toxic 
effects on skeletal muscle, as reported in animal studies (57, 58). 
Aminoglycoside is a widely used wide-spectrum antibiotic. 
Among its side effects, it is toxic to peripheral neurons and has 
well-known ototoxicity (59). The use of aminoglycoside increased 
the incidence of ICU-AW (OR, 2.27 ; 95% CI, 1.07–4.81 ; p < 0.05) 
(53).
2-6. Mechanical ventilation
Mechanical ventilation is associated with diaphragm atrophy 
(30). Diaphragm atrophy progresses rapidly after mechanical 
ventilation and prolonged mechanical ventilation is a risk factor 
for prominent atrophy (31). The extent of atrophy differs among 
ventilator settings. Excessive ventilatory support causes dia-
phragm atrophy (60). Based on diaphragm biopsy, the patient 
group without spontaneous breathing presented significant di-
aphragm atrophy (61). Positive end-expiratory pressure (PEEP) 
also resulted in diaphragm atrophy by excessive stretching of 
muscle fibers (62). These structural changes of the diaphragm 
are termed myotrauma, and recognized as a serious complica-
tion of mechanical ventilation (63).  
3. EVALUATION AND DIAGNOSIS
3-1. Physical assessment
Physical assessment is useful to evaluate muscle weakness. 
For ICU-AW, the medical research council (MRC) score is used 
for diagnosis (64). The MRC score is based on the manual testing 
of 6 muscle groups on both sides (0–60 score) (12). ICU-AW is 
defined as an MRC score of less than 48 without preexisting neu-
romuscular problems (64). As physical assessments require the 
patient’s cooperation, the assessment of ICU-AW was incomplete 
for 53.9% of mechanically ventilated patients and 51.2%–67.5% 
of acute respiratory distress syndrome (ARDS) patients (13, 




Ultrasound is the most commonly used method for monitoring 
of muscle mass because it is noninvasively available at the bed-
side (67). In contrast to assessment by MRC score, ultrasound 
can assess muscle atrophy for all critically ill patients regardless 
of their consciousness level and preadmission status. The mea-
surement is conducted using a linear transducer and generous 
amounts of gel to avoid compression of the muscles (67). However, 
the measurement site is not consistent among studies. The most 
common site of muscle mass measurement is the rectus femoris 
muscle. Its measurement is reproducible (R2 = 0.74–0.99) (17, 
21, 68) and needs only minimal training (69). The measurement 
site is midway or one-third from the proximal patella to the 
anterior superior iliac spine or 10 cm above the proximal patella 
(17, 21, 67, 70). Measurement by ultrasound should be conducted 
using the cross-sectional area (Fig. 2ab) rather than thickness 
because muscle thickness is inaccurate (71). Moreover, the 
Figure 1.　Risk factors associated with muscle atrophy 
Critically ill patients are exposed to numerous risk factors for muscle atrophy. PEEP, positive 
end-expiratory pressure
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cross-sectional area reflects the muscle strength (72). Although 
edema was reported to influence ultrasonographic assessment, 
it is not significant because most fluid is not retained in muscle 
and is instead in subcutaneous tissues (73, 74). The diaphragm 
thickness is evaluated by a perpendicularly placed transducer 
at 0.5–2 cm below the right costophrenic sinus, which is termed 
the zone of apposition (Fig. 2c) (75). The muscle echo intensity 
is useful for assessing muscle atrophy because it increases in 
atrophied muscle (22). This high intensity reflects the increased 
percentage of interstitial fibrous tissue (76). 
3-3. BIA (Bioelectrical impedance analysis)
BIA can be used at the bedside (Fig. 3). BIA indirectly mea-
sures whole-body muscle mass from the impedance using a weak 
electric current. The muscle mass, measured by BIA, correlates 
well with the CT assessment in critically ill patients (77). Howev-
er, edema complicates the impedance and muscle mass measure-
ment, and muscle mass was thus overestimated in edematous 
patients (77). Muscle mass monitoring during ICU stay may be 
unreliable because critical ill patients exhibit an abnormal fluid 
status (78).  
3-4. CT, MRI, and DEXA 
Computed tomography (CT), magnetic resonance imaging 
(MRI), and dual energy x-ray absorptiometry (DEXA) are re-
liable methods of muscle mass assessment but are unavailable 
at the bedside (79). Furthermore, CT and X-ray expose patients 
to extra radiation, and transferring patients to the examination 
room involves some risks. Therefore, these methods are not suit-
able for muscle mass monitoring in critically ill patients.
3-5. Biomarkers
Creatine kinase is normal or mildly high in ICU-AW, but it 
is not a specific biomarker (64, 65). Growth and differentiation 
factor-15 (GDF-15) is considered to be a mediator of muscle at-
rophy, and the level of GDF-15 increased in the muscle atrophy 
group (80). Furthermore, the GDF-15 level in plasma was higher 
in ICU-AW (7239 pg/mL vs. 2454 pg/mL, p = 0.001) (81). There-
fore, the measurement of GDF-15 is promising for the diagnosis 
of muscle atrophy. In a recent study, the serum creatinine to 
serum cystatin C ratio was reported to correlate with muscle 
mass (r  =  0.62, p <  0.001) (82), but it is limited to patients with-
out acute kidney injury. Under normal renal function, urinary 
creatinine and 3-methylhistidine are also useful for monitoring 
proteolysis and evaluating muscle atrophy (83, 84). 
4. PREVENTION AND TREATMENTS
As inflammation is the main cause of muscle atrophy in the 
early course of critical illness, treating the causative disease 
should be prioritized. As additional interventions, rehabilitation 
and nutritional support are indispensable for preventing muscle 
atrophy (Table 1). 
4-1. Physical therapy
Early mobilization has been demonstrated to be an effective 
method to prevent physical disabilities (85) and improve long-
term outcomes (86). Early physical therapy prevented muscle 
atrophy by preserving the muscle fiber cross-sectional area at 
day 7 of ICU admission (2.4% ± 22.5% in the intervention group 
vs. -25.8% ± 21.6% in the control, p = 0.005) (11). Moreover, early 
mobilization was confirmed to be effective in preventing ICU-AW 
(87). Physical therapy for respiratory muscles can improve both 
inspiratory and expiratory muscle strength (88). 
Figure 2.　Typical ultrasonographic images of upper limbs, lower limbs, and diaphragm 
a. Cross-sectional area of the biceps brachii muscle in the transverse plane. b. Cross-sectional area of the rectus femo-
ris muscle in the transverse plane. c. Diaphragm thickness from the right intercostal view.
Figure 3.　Bioelectrical impedance analysis
The whole-body muscle mass was measured by bioelectrical 
impedance analysis (InBody S10®, InBody Co., Seoul, South Korea). 
Patient consent was obtained for the use of this image.
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4-2. EMS (Electrical muscular stimulation) 
EMS uses electrical currents to induce muscle construction, 
and can be used safely as additional rehabilitation for ICU 
patients (Fig. 4) (89). EMS aided in preserving muscle mass in 
critically ill patients over the 7 or 8 days of ICU stay (cross-sec-
tional area of the rectus femoris muscle ; -8% ± 3.9% in the EMS 
group vs. -13.9% ± 6.4% in the control, p < 0.05) (90). In contrast, 
a recent study reported adding EMS to the lower legs did not 
preserve muscle mass at the day of ICU discharge (thickness of 
the rectus femoris ; -1.9 mm [-8.0 to 0.2 mm] in the intervention 
group vs. -2.4 mm [-7.1 to -0.3 mm] in the control, p = 0.17) (91). 
In this randomized controlled trial, early physical therapy was 
conducted for both groups (the control group had early stan-
dardized rehabilitation). Patients who have sufficient physical 
therapy may benefit little from EMS, but it may be useful for 
patients with limited mobility because active patient coopera-
tion is not required. Which patients will benefit the most from 
these additional rehabilitation methods needs to be clarified. In 
previous studies, EMS was effective for patients requiring a pro-
longed ICU stay (92) or prolonged mechanical ventilation (12). 
EMS preserved muscle thickness of the rectus femoris only in 
patients requiring long-term ICU stay (4.9% in the intervention 
group vs. -3.2% in the control, p = 0.013). Similarly, in patients 
under prolonged mechanical ventilation, the leg circumfer-
ence was preserved (47.5 ± 8.3 cm in the intervention group vs. 
44.6 ± 5.7 cm in the control, p = 0.004) (12). One previous study 
evaluated the effects of EMS on one side of the upper limbs, and 
the non-stimulated arm circumference decreased significantly 
over 13 days (-1.00 cm [IQR, -2.50 to 0.00 cm], p = 0.015) (93). 
However, the recommendation of EMS for critically ill patients 
is not consistent in the guidelines due to the limited number of 
studies (94, 95). 
EMS to the diaphragm through the phrenic nerve has been 
investigated in an animal study, and it was effective in prevent-
ing diaphragm muscle atrophy (diaphragm thickness/ initial 
value ; 1.10 [IQR, 1.02–1.24] in the intervention group vs. 0.84 
[IQR, 0.78–0.89] in the control, p = 0.001) (96). Its application in 
humans is currently under investigation (97).  
4-3 Ventilator settings
Ventilator settings preventing diaphragm muscle atrophy 
are termed “muscle-protective ventilation” (98). This strategy 
aims at maintaining spontaneous breathing and titrating ven-
tilatory support to obtain sufficient respiratory effort, but some 
patients with ARDS need ventilator settings without sponta-
neous breathing to avoid ventilator-induced lung injury (99). 
However, the setting without spontaneous breathing should be 
carefully used because this mode leads to prominent diaphragm 
atrophy of -7.5% ± 12.3% per day (60). Similarly, excessive re-
spiratory support should be avoided because higher inspiratory 
pressure leads to further diaphragm atrophy (daily atrophy 
ratio ; -5.6% ± 12.9% in ≥ 12 cmH2O vs. -1.5% ± 10.9% in 5–12 
cmH2O) (60). The optimal ventilator settings can be adjusted 
by ultrasonographic measurement of the diaphragm thickening 
fraction [thickness at inspiration – thickness at expiration]/
[thickness at expiration]×100 (%) (34). The diaphragm thicken-
ing fraction represents the respiratory effort by the patient (100). 
For better clinical outcomes, the thickening fraction should be 
maintained from 15% to 30%, which is the same range during 
spontaneous breathing in healthy adults (15). 
 
4-4 Nutrition
4-4-1 Early enteral and parenteral nutrition
Early enteral or parenteral nutrition is not promising for phys-
Table 1.　Strategies to prevent muscle atrophy in critically ill patients.
Summary of strategies aimed at preventing muscle atrophy in critically ill patients.
Recommendation was determined by the level of evidence. Recommended: based on meta-analysis, systematic review, or ran-
domized controlled trial. Moderately recommended: based on observational study. *The effects of electrical muscular stimula-
tion may vary in the included study population. 
Interventions Prevention of muscle atrophy Evidence
Limbs
Physical therapy Recommended (11), (85)
Electrical muscular stimulation Recommended with limitation* (12), (90), (92), (93)
Nutrition (timing, protein, calories) Unknown (101), (109)
Diaphragm
Inspiratory muscle training Recommended for muscle strength (88)
Electrical diaphragm muscle stimulation No clinical data (96), (97)
Maintaining  spontaneous breathing Moderately recommended (60), (61)
Titrating inspiratory pressure Moderately recommended (60)
Titrating PEEP No clinical data (62)
Figure 4.　Electrical muscular stimulation in a critically ill patient 
Bilateral upper and lower limbs were stimulated by electrical 
muscular stimulation (Solius, Minato Medical Science Co., Osaka, 
Japan). Patient consent was obtained for the use of this image.
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ical function. In a previous study, early and full enteral nutrition 
during the first 6 days did not change physical function 6 and 12 
months after ICU discharge (101). Similarly, early parenteral 
nutrition, compared with late parenteral nutrition beyond the 
first week, did not prevent muscle atrophy and only increased 
adipose tissue (102). Moreover, early parenteral nutrition was 
associated with ICU-AW (p = 0.021) (103), mainly due to unuti-
lized nutrition in the acute phase of critical illness (104). Indeed, 
63% of early intake is excreted (105). Hyperglycemia and dyslip-
idemia, which are common complications of early nutrition, are 
harmful to muscles and nerves (106).  
4-4-2 Protein
Protein intake from 1.2–1.5 or 1.2–2.0 g/kg/day is recom-
mended for lower mortality (107, 108). However, the necessary 
amount of protein to prevent muscle atrophy is unclear. In a 
randomized controlled trial of non-septic critically ill patients, 
protein intake was decided by nitrogen balance (difference 
between given amount and urinary excretion), and the actual 
protein intake was 1.47 g/kg/day in the intervention group vs. 
0.50 g/kg/day in the control. However, the higher protein intake 
did not change the physical quality of life at 6 months (109). In 
another study on septic patients, a higher protein intake was 
associated with prominent muscle atrophy (OR, 1.29 ; 95% CI, 
1.00-1.67 ; P < 0.049), possibly due to the deteriorated autophagy 
activity in septic patients (21, 110). In contrast, a higher protein 
intake was reported to increase the forearm muscle thickness on 
ultrasound (3.2 ± 0.4 cm vs. 2.8 ± 0.4 cm, p < 0.0001), although 
the actual difference in protein intake was small (0.9 g/kg vs. 1.1 
g/kg) (111). Results regarding the necessary amount of protein to 
prevent muscle atrophy are conflicting. The existence of negative 
data suggests that nutritional intervention alone is insufficient 
to prevent muscle atrophy, and that it should be combined with 
physical therapy.
4-4-3 Calories
In recent years, permissive underfeeding is recommended in 
the first week of critical illness (107, 109). In an observational 
study, low caloric intake on day 3 (< 10 kcal/kg/day) was associat-
ed with good physical status at ICU discharge (112). In another 
study, calorimetry-based full calorie intervention did not change 
the physical quality of life at 6 months (1877 kcal/day in the 
intervention group vs. 1061 kcal/day in the control) (109). The 
benefits of permissive underfeeding are being investigated in 
many trials. 
4-5 Glucose control
Intensive insulin therapy (blood glucose levels of 80 to 110 mg/
dl) reduced the incidence of ICU-AW (50.5% in the intervention 
group vs. 38.9% in the control, p = 0.02) (113). In addition to the 
benefits of preventing abnormal glucose levels, insulin can pro-
mote muscle anabolism (114). 
5. CONCLUSIONS
Progressive muscle atrophy occurs in critically ill patients 
because they are exposed to numerous risk factors. As muscle 
atrophy leads to poor clinical outcomes, muscle mass should be 
monitored by ultrasound because of its noninvasiveness and 
demonstrated utility. For prevention, rehabilitation and EMS 
will help preserve muscle mass, and their combination with 
nutritional management is promising. Further investigation 
is necessary to prevent muscle atrophy and improve long-term 
outcomes.
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